Biohit Oyj Stock Exchange Release
A. Matters on the agenda of the Annual General Meeting
1. Opening of the meeting
2. Calling the meeting to order
3. Election of persons to inspect the Minutes and supervise the counting of votes
4. Recording the legality of the meeting
5. Recording the attendance at the meeting and the list of votes
6. Presentation of the Financial Statements, the Report of the Board of Directors and the Auditor's Report for 2022
7. Adoption of the Financial Statements
2. Calling the meeting to order
3. Election of persons to inspect the Minutes and supervise the counting of votes
4. Recording the legality of the meeting
5. Recording the attendance at the meeting and the list of votes
6. Presentation of the Financial Statements, the Report of the Board of Directors and the Auditor's Report for 2022
7. Adoption of the Financial Statements
4. Recording the legality of the meeting
5. Recording the attendance at the meeting and the list of votes
6. Presentation of the Financial Statements, the Report of the Board of Directors and the Auditor's Report for 2022
7. Adoption of the Financial Statements
6. Presentation of the Financial Statements, the Report of the Board of Directors and the Auditor's Report for 2022
7. Adoption of the Financial Statements
The Board of Directors proposes that the Annual General Meeting adopts the annual accounts. The Auditor of the Company has supported the adoption of the annual accounts.
8. Resolution on the use of the profit shown on the Balance Sheet and on dividend payment / Board's proposal for distributions of profit
The Board of Directors proposes to the Annual General Meeting that the result for the financial period ended on 31st of
The parent company's distributable funds (unrestricted equity) on
9. Resolution on the discharge of the members of the Board of Directors and the CEO from liability
10. Resolution on the number and remuneration of the members of the Board of Directors
Shareholders representing more than 50% of the voting rights conferred by all company's shares have announced their intention to propose to the Annual General Meeting that the number of Board members be confirmed at five (5). These shareholders have announced their intention to propose to the Annual General Meeting that the meeting remuneration be paid to the Board members and the Chairman be unchanged as follows:
11. Election of Board Members
Shareholders representing more than 50% of the voting rights conferred by all company's shares have announced their intention to propose to the Annual General Meeting that the following persons be elected to the Company's Board of Directors until the end of the next Annual General Meeting:
12. Remuneration Report
The Board of Directors proposes that the Remuneration Report of the Company's governing bodies for 2022 be approved. The resolution is advisory in accordance with the Finnish Limited Liability Companies Act.
The Remuneration Report is available on the Company's website at https://www.biohithealthcare.com/en/investors/renumeration-reports/.
13. Resolution on the remuneration of the Auditor
The Board of Directors proposes to the Annual General Meeting that the Auditor to be elected be remunerated in according to an invoice approved by the Company.
14. Election of the Auditor
Shareholders representing more than 50% of the voting rights conferred by all company's shares have announced that
15. Closing of the meeting
The proposals for the decisions on the matters on the agenda of the Annual General Meeting as well as this notice are available on
The minutes of the meeting will be available on the aforementioned website as from
C. Instructions for the participants at the Annual General Meeting
1. The right to participate and registration
Shareholders who on the Annual General Meeting record date of Friday
Registration for the meeting will begin on
a) through the Company's website at https://www.biohithealthcare.com/en/investors/shareholder-meetings/annual-general-meeting-2023/. If the shareholder is an individual, electronic registration requires strong electronic authentication, which takes place either with a Finnish bank ID or a Finnish mobile certificate.
If the shareholder is a legal person, electronic registration requires either strong electronic authentication, or the book-entry account number and Business ID of the shareholder; or
b) by email to yhtiokokous@biohit.fi or by calling +358 20 770 6889.
When registering for the meeting, the following details shall be provided: the shareholder's name, personal identity number or Business ID, address, telephone number as well as the name of any proxy representative or assistant to be used, and the personal identity number of the proxy representative. The personal data given by shareholders to
The shareholder, their representative or proxy must be able to prove their identity and/or right of representation at the meeting, where necessary.
2. Shareowners with nominee-registered shares
Shareowners with nominee-registered shares have the right to participate in the Annual General Meeting on the basis of the shares held on the record date of the Annual General Meeting, i.e.
Shareholders with nominee-registered shares are encouraged to request without delay the necessary instructions concerning temporary registration with the Company's shareholder register, issuing proxy documents, and registration for the Annual General Meeting from their custodian bank. The account management organization of the custodian bank must register a shareholder with nominee-registered holdings, who wants to participate in the Annual General Meeting, temporarily into the Company's
3. Proxy representatives and powers of attorney
A shareholder may participate in the Annual General Meeting by way of proxy representation. A proxy representative shall produce a dated proxy document or otherwise in a reliable manner demonstrate their right to represent the shareholder at the Annual General Meeting. When a shareholder participates in the Annual General Meeting by means of several proxy representatives, representing the shareholder with shares in different book-entry accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Annual General Meeting.
Possible proxy documents should be delivered by regular mail to Yhtiökokous, Laippatie 1, 00880 Helsinki tai or by e-mail to yhtiokokous@biohit.fi before the end of the registration period. In addition to delivering the documents of proxy, the shareholder or his/her proxy shall ensure that they are registered for the General Meeting in the manner described above in this notice.
4. Other information
The language used in the meeting shall be Finnish.
A shareholder has the right to ask questions referred to in Chapter 5, Section 25 of the Finnish Limited Liability Companies Act with respect to the matters to be considered at the Meeting.
Any changes in the ownership of shares that occur after the record date of the General Meeting do not affect the right to participate in the General Meeting or the number of votes a shareholder may cast.
The information on the Annual General Meeting required by the Finnish Limited Liability Companies Act and the Securities Market Act is available on the Company's website at https://www.biohithealthcare.com/en/investors/shareholder-meetings/annual-general-meeting-2023/.
On
The Board of Directors
Additional information:
Chairperson of the Board
puh. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi
https://news.cision.com/biohit-oyj/r/notice-of-biohit-oyj-s-annual-general-meeting,c3773154
https://mb.cision.com/Main/18502/3773154/2075715.pdf
(c) 2023 Cision. All rights reserved., source